Adaptimmune Therapeutics PLC - - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ADAP Nasdaq 8731 http://www.adaptimmune.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adaptimmune Therapeutics PLC -

Adaptimmune Presents MAGE-A4 and MAGE-A10 pre-clinical data at American Association for Cancer Research (AACR) Annual Meeting - Apr 16th, 2018 12:00 pm
Adaptimmune Announces Changes to Board of Directors - Apr 12th, 2018 6:00 am
Report: Exploring Fundamental Drivers Behind Brookfield Property Partners, Grupo Financiero Galicia S.A, Adaptimmune Therapeutics, Radware, Mimecast, and Bandwidth — New Horizons, Emerging Trends, and Upcoming Developments - Apr 9th, 2018 5:30 am
Adaptimmune to Present Two Posters at the Upcoming American Association for Cancer Research (AACR) Annual Meeting - Apr 6th, 2018 6:00 am
4 Strong Buy Biotech Stocks Poised to Explode - Mar 29th, 2018 5:03 am
Adaptimmune Stock: How Long Will Rally Continue? - Mar 26th, 2018 8:50 am
GlaxoSmithKline prescribes commercial reboot for pharma division - Mar 21st, 2018 9:19 am
3 Hot Junior Biotech Plays - Mar 16th, 2018 8:10 am
Edited Transcript of ADAP earnings conference call or presentation 15-Mar-18 12:00pm GMT - Mar 15th, 2018 7:30 pm
Why Noodles & Co., Blue Apron Holdings, and Adaptimmune Therapeutics Jumped Today - Mar 15th, 2018 2:33 pm
Here's What Lifted Adaptimmune Therapeutics plc Today - Mar 15th, 2018 1:35 pm
Adaptimmune Therapeutics shares soar 26% on news of positive early signs for cancer treatment - Mar 15th, 2018 11:13 am
Adaptimmune Reports Fourth Quarter / Full Year 2017 Financial Results and Business Update - Mar 15th, 2018 5:30 am
Adaptimmune Announces Responses in Second Solid Tumor Indication with NY-ESO SPEAR T-cells - Mar 15th, 2018 5:30 am
Adaptimmune Therapeutics PLC Sponsored ADR to Host Earnings Call - Mar 15th, 2018 4:00 am
Investor Expectations to Drive Momentum within Methanex, YPF Sociedad Anonima, Adaptimmune Therapeutics, Horizon Pharma, Changyou, and China Yuchai International — Discovering Underlying Factors of Influence - Mar 13th, 2018 5:30 am
Adaptimmune to Report Fourth Quarter / Full Year 2017 Financial Results and Business Update on Thursday March 15, 2018 - Mar 5th, 2018 10:12 am
Did Adaptimmune Therapeutics plc’s (NASDAQ:ADAP) Recent Earnings Growth Beat The Trend? - Feb 12th, 2018 1:26 pm